---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-001885"
form_type: "8-K"
ticker: "WINT"
cik: "0000946486"
company_name: "WINDTREE THERAPEUTICS INC /DE/"
filed_at: "2023-01-26T23:59:59+00:00"
generated_at: "2026-06-20T09:00:27.627674+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Windtree Therapeutics amends warrants to $0.20/sh, raises ~$1M, issues 9.6M new warrants

## Summary
- Existing warrants for 4,808,595 shares exercised at reduced price of $0.20, gross proceeds ~$1.0M.
- Company issued new warrants to purchase up to 9,617,190 shares at $0.2152, exercisable after 6 months.
- New warrants expire 5 years from initial exercise date; beneficial ownership limit 4.99% (up to 9.99% opt-in).
- Ladenburg Thalmann served as placement agent, receiving 8% fee plus 1% management fee.
- Registration statement for resale of new warrant shares to be filed within 90 days.

## SEC filing metadata
- accession: 0001437749-23-001885
- form_type: 8-K
- ticker: WINT
- cik: 0000946486
- company_name: WINDTREE THERAPEUTICS INC /DE/
- filed_at: 2023-01-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 3.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946486/000143774923001885/0001437749-23-001885-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946486/000143774923001885/wint20230126_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-001885
- JSON: https://secwatch.observer/filing/0001437749-23-001885.json
- Plain text: https://secwatch.observer/filing/0001437749-23-001885.txt

## Key facts
- Material Agreements
  WINDTREE THERAPEUTICS INC /DE/ entered into Inducement Letters with certain holders of Existing Warrants valued at aggregate gross proceeds of approximately $1.0 million (effective 2023-01-20).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain holders of Existing Warrants
  - Value: aggregate gross proceeds of approximately $1.0 million
  - Effective: 2023-01-20
  source text: On January 20, 2023, Windtree Therapeutics, Inc. (the “Company”) entered into warrant exercise inducement offer letters (the “Inducement Letters”) with certain holders (the “Exercising Holders”) of certain of the Company’s: (i) warrants issued in December 2019 to purchase 78,643 shares of common stock
  evidence_url: https://www.sec.gov/Archives/edgar/data/946486/000143774923001885/0001437749-23-001885-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.